ArticleBioinformation2026
Seroprevalence of dengue virus infection in India.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue fever has emerged as a significant public health concern in India, with increasing incidence rates observed across various regions. The NS1 antigen detection provides early and accurate diagnosis of dengue infection. Hence, a retrospective cross-sectional study was conducted from January 2024 to December 2024 at MC Ratlam (MCH), analysing 178 laboratory-confirmed dengue cases using NS1 Ag ELISA from a total of 1,898 tested samples. Demographic, clinical and geographical data were collected and analysed using appropriate statistical methods. The overall seroprevalence of dengue was 9.38% among tested samples. The mean age was 28.1 ± 15.2 years, with males comprising 63.5% of cases. The highest incidence was observed in the 21-30 years age group (29.2%).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.